Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Masashi Taki
Postmarketing Safety and Effectiveness of Recombinant Factor IX (Nonacog Alfa) in Japanese Patients With Haemophilia B
Haemophilia
Medicine
Genetics
Hematology
Related publications
Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients With Rheumatoid Arthritis in Japan
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Identification of the Profile of the Patients With Hemophilia B Eligible for Treatment With Nonacog Alfa Once-Weekly
Reports — Medical Cases, Images, and Videos
Safety and Effectiveness of Sorafenib in Japanese Patients With Hepatocellular Carcinoma in Daily Medical Practice: Interim Analysis of a Prospective Postmarketing All-Patient Surveillance Study
Journal of Gastroenterology
Gastroenterology
Long-Term Safety and Effectiveness of Adalimumab for the Treatment of Japanese Patients With Rheumatoid Arthritis: 3-Year Results From a Postmarketing Surveillance of 552 Patients
Modern Rheumatology
Medicine
Rheumatology
Recombinant Factor VIIa for the Prevention and Treatment of Bleeding in Patients Without Haemophilia
Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Cost-Effectiveness Analysis of Prophylaxis vs On-Demand Supply of Factor Ix in Patients Diagnosed With Moderate Hemophilia B in Colombia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Management of Haemophilia B Patients With Inhibitors and Anaphylaxis
Haemophilia
Medicine
Genetics
Hematology
Perioperative Haemostasis With Full‐length, PEGylated, Recombinant Factor VIII With Extended Half‐life (Rurioctocog Alfa Pegol) in Patients With Haemophilia A: Final Results of a Multicentre, Single‐arm Phase III Trial
Haemophilia
Medicine
Genetics
Hematology
